The Effect of Sodium Channel Blocker, Mexiletine, on Body Weight in Type 2 Diabetes Patients with Visceral Obesity

OBJECTIVE: Mexiletine is an anti-arrhythmic agent also used for the treatment of painful diabetic neuropathy. In this study, the effect of mexiletine on body weight was evaluated in type 2 diabetes patients with diabetic neuropathy exhibiting visceral obesity. METHODS: Type 2 diabetes patients with...

Descripción completa

Detalles Bibliográficos
Autor principal: Ueno, Naohiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6343451/
https://www.ncbi.nlm.nih.gov/pubmed/30733634
http://dx.doi.org/10.1177/1179551418825049

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6343451/
https://www.ncbi.nlm.nih.gov/pubmed/30733634
http://dx.doi.org/10.1177/1179551418825049

Ejemplares similares